Intensive blood pressure lowering: a practical review
- PMID: 33292735
- PMCID: PMC7603713
- DOI: 10.1186/s40885-020-00153-z
Intensive blood pressure lowering: a practical review
Abstract
According to the last Hypertension guideline recommendations, it may be concluded that intensive BP lowering is only advisable in a subgroup of patients where there is a clear net benefit of targeting to lower BP goals. However, taking into account the relevance of correct BP measurement, estimates of the benefits versus the harm should be based on reliable office BP measurements and home BP measurements.There is still debate about which BP goals are optimal in reducing morbidity and mortality in uncomplicated hypertensives and in those with associated comorbidities. In recent years, trials and meta-analyses have assessed intensive BP lowering, with some success. However, a careful examination of the results shows that current data are not easily applicable to the general hypertensive population.This article reviews the evidence on and controversies about intensive BP lowering in general and in specific clinical situations, and the importance of obtaining reliable BP readings in patients with hypertension and comorbidities.
Keywords: Ageing; Ambulatory blood pressure measurement; Chronic kidney disease; Diabetes mellitus type 2; Heart failure; Intensive blood pressure lowering; Ischemic heart disease; Obesity, cardiovascular risk.
Conflict of interest statement
The Authors do not declare any competing interest.
References
-
- Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. Practice Guidelines for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension. Blood Press. 2018;27(6):314–340. doi: 10.1080/08037051.2018.1527177. - DOI - PubMed
-
- Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903–1913. doi: 10.1016/S0140-6736(02)11911-8. - DOI - PubMed
-
- Rapsomaniki E, Timmis A, George J, Pujades-Rodriguez M, Shah AD, Denaxas S, et al. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1,25million people. Lancet. 2014;383(9932):1899–1911. doi: 10.1016/S0140-6736(14)60685-1. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources